John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Immersion
IMMR
$254M
| $811K | ﹤0.01% |
+106,976
| New | +$878K |
|
2227
Erasca
ERAS
$6.21B
| $811K | ﹤0.01% |
591,637
-366,608
| -38% | -$629K |
|
2228
First Bank
FRBA
$445M
| $810K | ﹤0.01% |
54,714
+13
| +0% | +$191 |
|
2229
Invesco Russell 2000 Dynamic Multifactor ETF
OMFS
$286M
| $809K | ﹤0.01% |
+21,300
| New | +$841K |
|
|
PRO
2230
DELISTED
PROS Holdings
PRO
| $809K | ﹤0.01% |
42,503
+18,517
| +77% | +$432K |
|
2231
Vanda Pharmaceuticals
VNDA
$329M
| $806K | ﹤0.01% |
175,632
-23,828
| -12% | -$111K |
|
2232
First Advantage
FA
$3.49B
| $805K | ﹤0.01% |
57,123
-123,409
| -68% | -$2.07M |
|
2233
DNOW Inc
DNOW
$2.85B
| $803K | ﹤0.01% |
46,991
-260,721
| -85% | -$3.95M |
|
2234
Invesco S&P SmallCap Quality ETF
XSHQ
$316M
| $802K | ﹤0.01% |
+20,300
| New | +$839K |
|
2235
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.4B
| $802K | ﹤0.01% |
8,900
| – | – |
|
2236
VEON
VEON
$4.29B
| $800K | ﹤0.01% |
18,341
-11,145
| -38% | -$495K |
|
2237
Encore Capital Group
ECPG
$2.17B
| $798K | ﹤0.01% |
23,274
-96,568
| -81% | -$4.21M |
|
2238
Clearway Energy Class C
CWEN
$6.67B
| $792K | ﹤0.01% |
+26,175
| New | +$712K |
|
|
GRVY
2239
GRAVITY
GRVY
$508M
| $790K | ﹤0.01% |
13,050
-3,666
| -22% | -$219K |
|
2240
Invesco ESG NASDAQ 100 ETF
QQMG
$200M
| $788K | ﹤0.01% |
24,800
+14,200
| +134% | +$489K |
|
2241
Hawkins
HWKN
$2.47B
| $788K | ﹤0.01% |
+7,438
| New | +$817K |
|
2242
American Superconductor
AMSC
$1.44B
| $786K | ﹤0.01% |
43,357
+25,135
| +138% | +$627K |
|
2243
Tactile Systems Technology
TCMD
$534M
| $784K | ﹤0.01% |
59,278
+23,184
| +64% | +$365K |
|
2244
Core Laboratories
CLB
$553M
| $782K | ﹤0.01% |
52,160
-32,117
| -38% | -$538K |
|
2245
Ferrovial N.V. Ordinary Shares
FER
$45.4B
| $782K | ﹤0.01% |
+17,572
| New | +$758K |
|
|
ONTF
2246
DELISTED
ON24
ONTF
| $780K | ﹤0.01% |
149,914
-25,452
| -15% | -$158K |
|
2247
Compañía de Cervecerías Unidas
CCU
$2.32B
| $780K | ﹤0.01% |
51,283
-38,345
| -43% | -$506K |
|
2248
Five Point Holdings
FPH
$367M
| $777K | ﹤0.01% |
145,461
+48,990
| +51% | +$258K |
|
|
CCRD
2249
DELISTED
CoreCard
CCRD
| $776K | ﹤0.01% |
41,461
-7,177
| -15% | -$156K |
|
2250
Bit Digital
BTBT
$570M
| $772K | ﹤0.01% |
382,068
+204,917
| +116% | +$590K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.